Published in Gene Therapy Weekly, June 25th, 2009
"In the present article, the generation of a complementing Vero cell line suitable for the production of safe poxviral vaccines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.